Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,722,149
-$4,991,631 QoQ
Shares Held
1,134,229
-77.1% QoQ
Ownership
0.255%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 149 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Derivatives in LXRX
reported options exposure · as of Mar 31, 2025CallValue
$46,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. LXRX ranks #202 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in LXRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,722,149 | 1,134,229 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,713,780 | 4,944,731 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,544,992 | 4,821,733 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,171,391 | 3,830,660 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,561,100 | 1,643,264 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $46,000 | 100,000 | Call | Sole | 2025-05-15 | |
| 2024-09-30 | $2,196,235 | 1,398,876 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,003,499 | 597,321 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,282,041 | 534,184 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,498,759 | 1,633,176 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,235,470 | 3,885,753 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,032,256 | 2,634,173 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $57,940 | 23,844 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,247,242 | 1,176,567 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,174,186 | 905,911 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $405,383 | 217,948 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $770,486 | 368,654 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,005,243 | 255,138 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $375,357 | 78,037 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $825,534 | 179,855 | Shares | Sole | 2021-08-16 | |
| 2021-06-30 | $250,155 | 54,500 | Put | Sole | 2021-08-16 | |
| 2021-03-31 | $1,078,242 | 183,687 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,174,351 | 928,173 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $185,641 | 128,918 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||